Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
July 25, 2018

ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo

July 25, 2018-

ALPCO will exhibit at the AACC’s 70th Annual Clinical Lab Expo July 31-August 2, 2018 in Chicago, IL. The company will promote a number of tools to help research and improve clinical outcomes as well as increase laboratory efficiency. Among these tools are new and upcoming additions to ALPCO’s STELLUX® Chemiluminescence product line including fecal calprotectin, active GLP-1 (7-36) amide, and glucagon ELISAs. ALPCO is currently conducting ongoing clinical trials with the STELLUX® Chemiluminescence Calprotectin ELISA in order to establish the kit as a future tool for the diagnosis of Crohn's disease and ulcerative colitis.

 

ALPCO will also promote its comprehensive therapeutic drug monitoring portfolio consisting of ten colorimetric ELISAs. The therapeutic drug monitoring assays offer a reliable method to research optimal concentrations, immune responses, and the influence of anti-drug antibodies on biologics which can lead to improving clinical outcomes for inflammatory bowel disease. Laboratory professionals can visit ALPCO at the Clinical Lab Expo to learn about maximizing lab productivity with ALPCO’s complete gastroenterology ELISA testing panel  and the FDA Class I Exempt Easy Stool Extraction Device . By using both tools together, lab technicians can replace manual weighing with one simple extraction step, while increasing the efficiency and reliability of measuring biomarkers such as pancreatic elastase-1.

 

In addition, AACC Clinical Lab Expo attendees can learn about ALPCO’s assay qualification program which assists laboratories with transitioning to in-house testing. “Our assay qualification program was developed to help institutions save time and ease the burden of onboarding new tests,” said ALPCO President Sean Conley. “Ultimately, our aim is to allow for savings that will result in lower overall healthcare costs in the industry.” Visit ALPCO in booth 3467 at the AACC’s 70th Annual Clinical Lab Expo to learn more about these tools and services to help improve clinical outcomes and increase productivity in the lab.